Navigation Links
ChromaDex Announces 2008 Year End Financial Results
Date:4/3/2009

IRVINE, Calif., April 3 /PRNewswire-FirstCall/ -- ChromaDex Corporation, (OTC Bulletin Board: CDXC) a leader in phytochemical reference standards and contract research, today announced financial results for the 2008 Fiscal Year. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.07 per share for the twelve months ended January 3, 2009.

As of January 3, 2009, cash, cash equivalents, and marketable securities totaled $1 million.

"The FDA started implementing Good Manufacturing Practices for dietary supplements in June 2008," said Frank Jaksch, CEO and co-founder of ChromaDex. "There is a rapidly growing awareness both at the consumer and government regulatory level of the need for reference standards, analytical methods and other quality assurance methods to insure that products on the shelf not only contain what is claimed on the label, but are also safe and effective. We are confident that the increased awareness and demand for products that are healthy, natural, organic or green, will continue to provide an opportunity for ChromaDex. Additionally, we will continue to invest in products, services and intellectual property that will enable us to remain the reference standards market leader for the dietary supplement, food, beverage, personal care, and sport nutrition markets."

Additional Financial Results & Notes

On a reported basis, ChromaDex recorded revenue during 2008 of $4,506,301 as compared to $4,754,073 for the same period in 2007. The net loss attributable to common stockholders for the twelve months ended January 3, 2009, was $2,104,476 as compared to a net loss of $189,875 for the same period in 2007. The company notes that as a result of its closing of the reverse merger acquisition of Cody Resources, Inc. on June 20, 2008, investors are cautioned t
'/>"/>

SOURCE ChromaDex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ChromaDex Announces Second Quarter 2008 Financial Results
2. ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc.
3. China Agri-Business Announces 2008 Operating Results
4. Verenium Announces Organizational Changes
5. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
6. Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis
7. Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis
8. Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc.
9. China Biologic Products Announces Strong 2008 Results
10. Senetek PLC Announces New Investor Communication Hotline
11. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a pre-market ... (FDA) for the use of Medtronic,s SynchroMed ® ... catheter) for use with United Therapeutics, Remodulin ® ...
(Date:12/24/2014)... Missouri (PRWEB) December 23, 2014 GMO corn ... company, Syngenta, are in the process of being consolidated in ... is In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... of Kansas. , Management of the Syngenta GMO corn multidistrict ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 The ... as its definition, classification, application and industry overview. ... and product cost structure. Production is separated by ... upstream raw materials, equipment, downstream client survey, marketing ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... of Wisconsin-Madison spinout that has sped to the finals in ... stop to the annual flu vaccine hoopla, among other things. ... are developing two drugs based on antiviral peptides discovered in ... while the other targets some sexually transmitted viruses such as ...
... recent decision to pull Pfizer Cox-2 inhibitor Bextra from the marketplace ... up in the Merck Vioxx dilemma months ago and its stock ... $25 per share in February. It has recently moved up to ... about 30 percent in the last 12 months. , ,Though Pfizer ...
... Sensient Technologies Corp. (NYSE:SXT) reported $12.8 million ... quarter ended March 31. Diluted earnings per share were 27 ... flavors and fragrances. , ,Revenue was down $3 million since ... a reduction of $19.2 million. , ,Results for the first ...
Cached Biology Technology:UW-Madison spinoff Pedrus finds more to business planning than good science 2UW-Madison spinoff Pedrus finds more to business planning than good science 3Why are new drugs failing? 2Why are new drugs failing? 3Why are new drugs failing? 4Why are new drugs failing? 5Why are new drugs failing? 6
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel experience and ... Over the past decade, ePassports, biometric readers, and secure ... through border control via eGates and Automated Passport Control ... and land borders across the globe. ...
(Date:12/11/2014)... Research and Markets , ... announced the addition of the "Biometrics Market in ... One major trend emerging in this market ... it is important to upgrade biometric solutions to the ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... severed nerves could result in patients recovering in days or ... cellular mechanism similar to that used by many invertebrates to ... in the Journal of Neuroscience Research . "We ... minutes so that the behavior they control can be partially ...
... that make up half the biomass in the oceans ... over, mostly remain enigmatic. A few abundant groups have ... of the rest remain mysterious. Understanding how the ... is like trying to understand the solar system when ...
... fertile, excite our most basic urges, and as scientists have ... from women. But how? Now a team of scientists ... many genes influenced by the male and female sex hormones ... of male and female behaviors in mice. The UCSF ...
Cached Biology News:New procedure repairs severed nerves in minutes, restoring limb use in days or weeks 2Scientists coax shy microorganisms to stand out in a crowd 2Scientists coax shy microorganisms to stand out in a crowd 3Male and female behavior deconstructed 2Male and female behavior deconstructed 3Male and female behavior deconstructed 4
General description: MaxiSorp TM surface is ideal for arraying molecules with mixed hydrophilic/hydrophobic domains such as proteins ID clarifier: Maxisorp(tm) with lid...
... TRAC is a platform for fully automated ... It can easily be configured for applications ... molecular biology.TRAC allows closed loop screening, which ... hit list generating, cherry picking and follow ...
... Building on over 20 years of ... for the Life Sciences, the Freedom EVO ... for expansion according to future needs. Together ... each system is equipped to successfully operate ...
... Series Systems provide fast and reliable ... proteomics and drug development laboratories. Staccato ... customer specifications, providing solutions that are ... Staccato Custom Systems are controlled with ...
Biology Products: